Mangalam Drugs jumps on entering into technology transfer agreement with Nigerian Group

12 Aug 2021 Evaluate

Mangalam Drugs And Organics is currently trading at Rs. 158.75, up by 15.25 points or 10.63% from its previous closing of Rs. 143.50 on the BSE.

The scrip opened at Rs. 146.80 and has touched a high and low of Rs. 162.80 and Rs. 146.80 respectively. So far 28356 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 196.50 on 27-Jul-2021 and a 52 week low of Rs. 91.00 on 31-Mar-2021.

Last one week high and low of the scrip stood at Rs. 176.90 and Rs. 134.00 respectively. The current market cap of the company is Rs. 251.04 crore.

The promoters holding in the company stood at 50.53%, while Institutions and Non-Institutions held 0.01% and 49.46% respectively.

Mangalam Drugs & Organics has entered into a Technology Transfer Agreement with a $70 Million leading pharmaceutical company / group in Nigeria, Africa region, for providing them in-house developed technology. The company will provide an in-house developed technology for manufacturing certain Anti-Malaria Active Pharmaceutical Ingredients (APIs) on limited, nontransferable and exclusive license basis for certain agreed territory.

The company will also provide consultation and relevant designs for setting up an API manufacturing facility for manufacturing of the said APIs, for which the company is one of the leading manufacturers. It is expected to be a world class API facility and one of its kind in Africa region. The said manufacturing facility is expected to become operational in coming 15 to 18 months. Apart from the agreed fixed consideration for the technology transfer, the company would also be entitled to receive a 2% royalty on sales for the next 20 years. The company has received an advance/token payment of $500,000 towards the agreed fixed consideration, which is reflected as an advance in the books of accounts of the company for the quarter ending June 30, 2021.

Mangalam Drugs and Organics is an India-based company engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The Company’s segments include bulk drugs, and chemicals and others.

Mangalam Drugs&Org. Share Price

25.34 0.01 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×